2 results
Approved WMOCompleted
To provide continued bevacizumab therapy as single agent or in combination with an anti-cancer drug to patients with cancer, who were previously enrolled in a F. Hoffmann-La Roche (Roche)/ Genentech sponsored bevacizumab study (i.e. the Parent, P-…
Approved WMOCompleted
The objective of the study is the assessment of the effect of the use of the 'free style navigator continuous monitoring system' on the glucose variability in patients with type 1 diabetes mellitus. This assessment is combined with the…